The United Kingdom (UK) on Wednesday recognized Covishield as an approved Covid19 vaccine for travellers visiting the country.
This new rule will come into force from 4 AM onwards on October 4, 2021.
In its new travel advisory, the UK government said a person will qualify as fully vaccinated if he or she is inoculated with a full course of the Oxford/AstraZeneca, Pfizer BioNTech, Moderna or Janssen vaccines from relevant public health bodies.
“From 4 AM, October 4, you will qualify as fully vaccinated if you are vaccinated under an approved vaccination programme in the UK, Europe, USA or UK vaccine programme overseas with a full course of the Oxford/AstraZeneca, Pfizer BioNTech, Moderna or Janssen vaccines from a relevant public health body in Australia, Antigua and Barbuda, Barbados, Bahrain, Brunei, Canada, Dominica, Israel, Japan, Kuwait, Malaysia, New Zealand, Qatar, Saudi Arabia, Singapore, South Korea or Taiwan,” the advisory stated.
It also mentioned that formulations of the four listed Covid19 vaccines, such as AstraZeneca Covishield, AstraZeneca Vaxzevria and Moderna Takeda will qualify as approved vaccines.
“You must have had a complete course of an approved vaccine at least 14 days before you arrive in England,” it added.
However, Indians who have taken the Covishield vaccine will still have to remain in quarantine due to a ‘certification’ issue according to the UK government.
The new change in travel rules of the UK comes amidst a number of Indians condemning the country for its earlier decision of exempting Covishield from the list of approved Covid19 vaccines for travellers.